2-(n,n-dipropyl)amino-5,6-dihydroxytetralin has been researched along with oxidopamine in 1 studies
| Studies (2-(n,n-dipropyl)amino-5,6-dihydroxytetralin) | Trials (2-(n,n-dipropyl)amino-5,6-dihydroxytetralin) | Recent Studies (post-2010) (2-(n,n-dipropyl)amino-5,6-dihydroxytetralin) | Studies (oxidopamine) | Trials (oxidopamine) | Recent Studies (post-2010) (oxidopamine) |
|---|---|---|---|---|---|
| 37 | 0 | 0 | 8,630 | 6 | 2,407 |
| Protein | Taxonomy | 2-(n,n-dipropyl)amino-5,6-dihydroxytetralin (IC50) | oxidopamine (IC50) |
|---|---|---|---|
| Glyceraldehyde-3-phosphate dehydrogenase | Homo sapiens (human) | 8 | |
| DNA repair protein RAD52 homolog | Homo sapiens (human) | 0.779 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feenstra, MG; Horn, AS; Mulder, TB; Rollema, H; Westerink, BH | 1 |
1 other study(ies) available for 2-(n,n-dipropyl)amino-5,6-dihydroxytetralin and oxidopamine
| Article | Year |
|---|---|
In vivo dopamine receptor binding studies with a non-radioactively labeled agonist, dipropyl-5,6-ADTN.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Cerebellum; Corpus Striatum; Domperidone; Female; Homovanillic Acid; Hydroxydopamines; Male; Methysergide; Naphthalenes; Occipital Lobe; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sympatholytics; Tetrahydronaphthalenes; Tranquilizing Agents | 1983 |